MarketInOut Stock Screener Log In | Sign Up
 

Cosmo Pharmaceuticals N.V.

SIX • Healthcare • Drug Manufacturers - General • Quote as of 07/29/2026 15:30
Cosmo Pharmaceuticals N.V. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeSIX
Market Capitalization1,182.01 mln
Float8.69 mln
Earnings Date07/23/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-4.54
Highly reliable

1-Year Forecast

130
Transformational upside

Relative Strength

21 / 100
Significantly lagging

Debt / Equity

0.01
Debt-free

ROE

-1.26
Negative

Business Description

Founded in Dublin in 1997, Cosmo N.V. is an Ireland-based life sciences company that creates and produces medical treatments and technology for digestive health, skin conditions, and related fields across global markets. Its current lineup includes products that help detect and treat colon abnormalities, manage inflammatory bowel conditions, address acne, and combat traveler's diarrhea, alongside an AI-powered endoscopy tool that helps doctors spot colorectal lesions in real time. The company is also advancing several treatments through clinical trials, targeting conditions such as ulcerative colitis, bile acid diarrhea, male pattern hair loss, and certain solid tumor cancers.

Key Fundamentals

EPS-0.21
ROE-1.26
RPS5.78
ROIC-2.58
ROA-0.99
EBITDA, mln8.57
EV / EBITDA88.62
EV / EBIT-1,327
Revenue, mln95.21
EV / Revenue10.17

Financial Strength

Altman Z-Score6.9
Piotroski F-Score 2 / 9
Beneish M-Score-4.54
1-Year Target Price130
Shiller PE Ratio209

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.5% 22 / 100   
1 Month -6.32% 15 / 100   
2 Months -33.48% 1 / 100   
6 Months -46.38% 2 / 100   
1 Year -0.02% 22 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us